Condition
Refractory Glaucoma
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 11 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
11 shownThe Vizio Clinical StudyNCT06591117 · 2026-03-21
RECRUITINGEfficacy and Safety of Posterior Chamber Glaucoma Drainage DeviceNCT07003685 · 2024-08-02
ENROLLING_BY_INVITATIONComparison Between Two Techniques of Subthreshold Diode Laser Cyclophotocoagulation in Refractory GlaucomaNCT05230355 · 2022-02-01
COMPLETEDCPC in Adult Refractory GlaucomaNCT04921098 · 2021-07-01
UNKNOWNMicroPulse Transscleral Laser Cyclophotocoagulation With the Zig Zag Mode in Glaucoma.NCT05521334 · 2021-03-01
COMPLETEDReal-world Evidence Study of XEN in Chinese Patients With Refractory GlaucomaNCT04303897 · 2019-12-19
COMPLETEDAhmed Valve Glaucoma Implant With Adjunctive Subconjunctival Bevacizumab in Refractory GlaucomaNCT01128699 · 2010-05-01
UNKNOWNUse of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind EyeNCT01404364 · 2010-01-01
COMPLETEDSafety Study of Conventional Versus Micropulse Transscleral Cyclophotocoagulation in Treating End-Stage GlaucomaNCT00349414 · 2006-07-01
UNKNOWNAhmed Glaucoma Valve and Single-Plate Molteno Implants in Treatment of Refractory GlaucomaNCT00971061 · 2003-01-01
COMPLETEDAhmed Glaucoma Valve Alone, With Amniotic Membrane or With Mitomycin C (MMC) for Treatment of Refractory GlaucomaNCT00893490
UNKNOWNCommon interventions
Ahmed Valve implantDEVICE2Ahmed Glaucoma Valve (AGV)DEVICE1amniotic membrane coveragePROCEDURE1ChlorpromazineDRUG1Conventional Transscleral CyclophotocoagulationPROCEDURE1Diode Laser CyclophotocoagulationPROCEDURE1GDD in aterior chamberDEVICE1GDD in posterior chamberDEVICE1Micropulse Transscleral CyclophotocoagulationPROCEDURE1micropulse transscleral cyclophotocoagulationDEVICE1Mitomycin C (MMC)DRUG1modified patternDEVICE1Molteno single-plate implant (MSPI)DEVICE1standard techniqueDEVICE1Subconjunctival AvastinDRUG1TriamcinoloneDRUG1Vizio Aqueous MicroshuntDEVICE1XEN Glaucoma StentDEVICE1
Leading sponsors
Trial status mix
COMPLETED5
UNKNOWN4
ENROLLING_BY_INVITATION1
RECRUITING1
Phase mix
NA6
PHASE12
PHASE32
PHASE21
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.